ProMIS Neurosciences to Present New Preclinical Data for PMN310 at AD/PD 2023

ProMIS Neurosciences Inc. (TSX: PMN) (Nasdaq: PMN), a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), today announced that new preclinical data for ProMIS’ lead candidate for AD, PMN310, will be […]

Continue Reading

Leading Tokenization Firm DigiShares Introduces Three New Solutions

DigiShares, a global provider of infrastructure for tokenization of real-world assets, has recently introduced three new configurations of its market leading platform, to cater for three different market segments. This enables DigiShares to support the main three tokenization use cases, crypto-settled, fiat-settled, and internally settled. Each configuration is optimized for full automation and ease of […]

Continue Reading

ProMIS Neurosciences Announces Full Year 2022 Financial Results and Recent Highlights

ProMIS Neurosciences Inc. (TSX: PMN) (Nasdaq: PMN), a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), today announced its full year 2022 financial results and recent highlights.   Completed all preclinical […]

Continue Reading

Promis Neurosciences to Present at the Oppenheimer 33rd Annual Healthcare Conference

ProMIS Neurosciences Inc. (TSX: PMN) (Nasdaq: PMN), a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), today announced that Gail Farfel, Ph.D., Chief Executive Officer, will present at the upcoming Oppenheimer […]

Continue Reading

Quorum Unveils Bolstered Product Offering Tailored for EU Affairs Professionals

With Quorum Communications and powerful legislative tracking all in one place, you can get your story to the press and to policymakers at the same time.   Quorum, best-in-class software for public affairs, today announces a refreshed and reinforced product offering, specifically tailored towards EU affairs professionals. The update is based on two flagship tools: […]

Continue Reading

World’s Biggest Food Manufacturers Over Reliant on Sales of Unhealthy Foods – New Analysis Reveals

Four of the world’s biggest food manufacturers are over reliant on the sales of unhealthy food despite each claiming to be active in improving the healthfulness of their products – that’s according to NEW analysis published today by expert research group, World Action on Salt, Sugar & Health (WASSH) and supported by responsible investment NGO, […]

Continue Reading

DigiShares announces the launch of its own Security Token Offering – available to non-US investors and US accredited investors

DigiShares is kicking off its Series A capital raise today. The raise is taking the form of a Security Token Offering (STO). The tokens will be minted on the Ethereum chain. Investors will be able to purchase ERC-1404 security tokens representing ownership in DigiShares’ Delaware Corporation.   DigiShares will use its own white-label tokenization platform […]

Continue Reading